Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alpha ointment versus hydrocortisone for radiation dermatitis after postmastectomy radiotherapy in breast cancer
ACTRN12612000837820Phase 2Recruiting
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of alpha and hydrocortisone in radiodermatitis (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Rate of healing of radiation dermatitis. Started Mar 2011; status: recruiting.
02
Drugs
alphahydrocortisone
03
Conditions
radiodermatitis
Beyond the preview
Go deeper on ACTRN12612000837820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000837820.